Financials

  • Market Capitalization 8.79 B
  • Employee 315
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.97
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
943
PTGX
Protagonist Therapeutics, Inc. - Common Stock
146.29 USD-2.15%-3.66%+6.86%+94.72%9.47 B USD
981
PCVX
Vaxcyte, Inc. - Common Stock
60.25 USD-1.49%-5.06%+10.55%+42.43%8.97 B USD
992
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.86 USD+0.01%+0.15%+1.16%+106.47%9.00 B USD
993
ABVX
Abivax SA - American Depositary Shares
114.55 USD+0.22%-4.34%-8.29%+39.70%9.00 B USD

Haberler